Research ArticleBasic Science Investigation
211At- and 131I-Labeled Bisphosphonates with High In Vivo Stability and Bone Accumulation
Roy H. Larsen, Kristin M. Murud, Gamal Akabani, Per Hoff, Øyvind S. Bruland and Michael R. Zalutsky
Journal of Nuclear Medicine July 1999, 40 (7) 1197-1203;
Roy H. Larsen
Kristin M. Murud
Gamal Akabani
Per Hoff
Øyvind S. Bruland


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
211At- and 131I-Labeled Bisphosphonates with High In Vivo Stability and Bone Accumulation
Roy H. Larsen, Kristin M. Murud, Gamal Akabani, Per Hoff, Øyvind S. Bruland, Michael R. Zalutsky
Journal of Nuclear Medicine Jul 1999, 40 (7) 1197-1203;
Jump to section
Related Articles
- No related articles found.
Cited By...
- The {alpha}-Camera: A Quantitative Digital Autoradiography Technique Using a Charge-Coupled Device for Ex Vivo High-Resolution Bioimaging of {alpha}-Particles
- High-Linear Energy Transfer Irradiation Targeted to Skeletal Metastases by the {alpha}-Emitter 223Ra: Adjuvant or Alternative to Conventional Modalities?
- First Clinical Experience with {alpha}-Emitting Radium-223 in the Treatment of Skeletal Metastases
- Radiopharmaceutical Chemistry of Targeted Radiotherapeutics, Part 1: Effects of Solvent on the Degradation of Radiohalogenation Precursors by 211At {alpha}-Particles
- 123I-Labeled Chitinase as Specific Radioligand for In Vivo Detection of Fungal Infections in Mice
- Targeting of Osseous Sites with {alpha}-Emitting 223Ra: Comparison with the {beta}-Emitter 89Sr in Mice
- Significant Antitumor Effect from Bone-seeking, {alpha}-Particle-emitting 223Ra Demonstrated in an Experimental Skeletal Metastases Model
- Overcoming the Obstacles to Clinical Evaluation of 211At-Labeled Radiopharmaceuticals